Dr. Stamatia Pouliliou is post-doctoral researcher at the Department of Radiotherapy and Oncology, School of Medicine, Democritus University of Thrace (RO / MED / DUTH) in Alexandroupoli (Greece) . She has a degree in Biology (2008, University of Patras), an MSc in Clinical Pharmacology and Therapeutics (2011, DUTH) and a PhD in Radiotherapy and Oncology, School of Medicine, with emphasis on the development of evaluation methods of the internal radiosensitivity and cytoprotective action of amifostine in cancer patients under radiotherapy (2014, DUTH). She has participated as postdoctoral researcher in 2 Greek national projects (Metaboli-CA and TALK project), as a study coordinator in a multicenter, randomized, open-label, parallel-group study (LPS14584 (Sanofi), DUTH site) and as a pilot leader in a randomized, single-blind, controlled study (CARRE Project (EU FP7-ICT), DUTH site). Moreover, she has 34 papers in peer-reviewed journals (h-index:14, i10-index:18) and 20 participations in conferences. She has a broad range of molecular, cellular and biochemistry techniques, a substantial troubleshooting capacity, a very good initiative in research and excellent skills in organizing and work planning.